Inspire2Live - Syneratio honoured to be keynote speaker
We are proud and honoured to announce that we are invited to be keynote speaker at the Inspire2Live congress next Thursday (11 February 2016). Inspire2live is an independent patient advocacy organization that makes a difference for cancer patients: a charity organisation to achieve the best possible cancer care and the best possible access to cancer care. Inspire2Live is the initiative of Peter Kapitein, founder of the Dutch famous ‘Alpe d’HuZes’annual charity event for cancer research, that started with $350,000 worth of sponsoring contracts, growing five years later towards $30M annually. The reason why we are invited to speech, is that Inspire2Live and Syneratio have a mutual vision on the world of science: Scientific knowledge should be extracted faster from laboratories to the ones who need it the most. In case of Inpsire2Live: the patients. Only when scientific knowledge will be shared and used accordingly among stakeholders in all processes around cancer as a disease, innovation is possible. As Inspire2Live dictates: Let’s get cancer under control. One of the key issues is to break down the scientific silos. The data that was collected for, e.g. prostate cancer goes into the silo where it can only be used for prostate cancer. This data should be networked and be integrated to a broader scale for the fight against cancer. Inspire2Live optimizes research and stimulates international cooperation in research to take care of knowledge sharing among stakeholders (patients, doctors, etc.). We both break down the silos in research and healthcare and stimulate multidisciplinary collaboration. Members of Inspire2Live have invested a lot of energy and time during the last years in setting up cancer research in cooperation with patients, clinicians and researchers and always with the aim of implementing the best cancer care and the access to the best cancer care in various countries. John Locke (1632 – 1704), the famous English philosopher once said: “The improvement of understanding is for two ends: First, our own increase of knowledge; secondly, to enable us to deliver that knowledge to others.” Let’s enable us to deliver that knowledge to others, the ones who need it the most! For us at Syneratio, if we could change even a tiny bit in the lives of patients suffering from cancer, we would be honoured. Let’s use all of that data for that basic purpose: People from around the world active at our platform, the millions of scientific articles present and a multitude of cross-functional links between these data entries, just to accomplish this mission to improve people’s lives in a different way.



















